Research
FORUM TRANSCRIPT

Bausch + Lomb – Standalone Eyecare Business Analysis & Strategic Outlook – 22 December 2021

  • Credit
  • Healthcare
  • North America
PREMIUM

Specialist

Former Director at Bausch + Lomb Inc

Agenda

  • Recent trends and developments in the global eyecare market
  • Spin-off of Bausch + Lomb from Bausch Health (TSE: BHC) and standalone business analysis
  • R&D efforts to drive innovation in surgical business and IOL (intraocular lens) offerings
  • Competitive positioning vs Alcon, Carl Zeiss and Johnson & Johnson (NYSE: JNJ), highlighting clinician relationships and product bundling ability
  • 2022 outlook – strategic assessments and turnaround potential

Questions

For access to this and thousands of other Transcripts, request a free trial

Request A Demo